Form 4: Ceribell Director Sells Shares Under 10b5-1 Plan

Ceribell Director Josef Parvizi sold 16,714 shares of common stock for a weighted average price of $20.27 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Josef Parvizi, a Director of Ceribell, Inc. (CBLL), reported the sale of 16,714 shares of common stock.
• The transaction occurred on February 19, 2026.
• The shares were sold at a weighted average price of $20.27 per share, with individual sales ranging from $20.00 to $20.77.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Parvizi on August 18, 2025.
• Following this transaction, Mr. Parvizi's beneficial ownership includes 722,652 shares indirectly held through the Josef Parvizi Trust, 907,911 shares through the Innovation ACP Trust, and 369,088 shares through the ACP 2021 Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale can sometimes be perceived negatively, the execution under a pre-arranged 10b5-1 plan mitigates concerns about it being based on new, non-public information.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on immediate, non-public information.

Negatives

• A director selling shares can sometimes be perceived negatively by the market, as it reduces their direct stake in the company.

Future Outlook

No future outlook or guidance is provided in this Form 4 filing, as it is a report of a completed insider transaction.

Industry Context

StockSavvy.ai notes that insider sales, even when pre-scheduled under a 10b5-1 plan, are routinely monitored by investors for insights into management's perception of future stock performance. While this sale is not necessarily a bearish signal due to the 10b5-1 plan, it's a common practice for executives to diversify holdings.

Comparison to Industry Standards

• Form 4 filings are standard regulatory disclosures for insider transactions across all publicly traded companies in the U.S.
• There are no specific industry benchmarks for the volume or frequency of insider sales, as these are individual decisions often driven by personal financial planning rather than company performance relative to peers.

Stakeholder Impact

• Shareholders may note the director's reduction in direct shareholding, though the overall beneficial ownership remains substantial through trusts.

Key Dates

Recommendation

The filing reports a routine insider sale executed under a pre-established 10b5-1 plan, which is a common practice for diversification and personal financial planning. It does not provide new information about the company's operational performance or strategic direction that would warrant a change in investment recommendation. Investors should continue to monitor Ceribell's fundamental performance and broader market trends.

Keywords

Ceribell Inc., CBLL, Josef Parvizi, Director, Insider Trading, Form 4, SEC Filing, Stock Sale, 10b5-1 Plan, Beneficial Ownership